Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Brain-Gut Connection Increases satiety and slows gastric emptying, reducing caloric intake
Mortazavi M, Moosavi F, Martini M, Giovannetti E, Firuzi O
The key is medical necessity
Stay away from store-bought baked goods like cookies and cakes
The SURMOUNT-1 trial reported the following side effect rates among participants taking tirzepatide: Nausea: up to 20% of participants Diarrhea: approximately 16% Constipation: approximately 11% Decreased appetite: this is expected and often the desired mechanism of action Vomiting: approximately 6 to 9% Injection site reactions: mild, infrequent Most side effects peak during the first one to two weeks after each dose increase and then gradually subside as the body adapts
But until then, tirzepatide is the only dual-agonist option available outside of clinical trials
